These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 24264044)

  • 1. Pathogenesis of chronic cardiorenal syndrome: is there a role for oxidative stress?
    Rubattu S; Mennuni S; Testa M; Mennuni M; Pierelli G; Pagliaro B; Gabriele E; Coluccia R; Autore C; Volpe M
    Int J Mol Sci; 2013 Nov; 14(11):23011-32. PubMed ID: 24264044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Renal Oxidative Stress in the Pathogenesis of the Cardiorenal Syndrome.
    Giam B; Kaye DM; Rajapakse NW
    Heart Lung Circ; 2016 Aug; 25(8):874-80. PubMed ID: 27132623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Organ damage and cardiorenal syndrome in acute heart failure].
    Casado Cerrada J; Pérez Calvo JI
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():26-31. PubMed ID: 24930080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiorenal Syndrome Revisited.
    Zannad F; Rossignol P
    Circulation; 2018 Aug; 138(9):929-944. PubMed ID: 30354446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAAS inhibition and cardiorenal syndrome.
    Onuigbo MA
    Curr Hypertens Rev; 2014; 10(2):107-11. PubMed ID: 25549841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apocynin Attenuates Cardiac Injury in Type 4 Cardiorenal Syndrome via Suppressing Cardiac Fibroblast Growth Factor-2 With Oxidative Stress Inhibition.
    Liu Y; Liu Y; Liu X; Chen J; Zhang K; Huang F; Wang JF; Tang W; Huang H
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26109504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qiliqiangxin Protects against Renal Injury in Rat with Cardiorenal Syndrome Type I through Regulating the Inflammatory and Oxidative Stress Signaling.
    Duan X; Yan F; Hu H; Liu H; Wu Q; Sun S; Ming X; Bu X; He Y; Zhu H
    Biol Pharm Bull; 2018; 41(8):1178-1185. PubMed ID: 30068867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrosis, the Bad Actor in Cardiorenal Syndromes: Mechanisms Involved.
    Delgado-Valero B; Cachofeiro V; Martínez-Martínez E
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular apoptosis in the cardiorenal axis.
    Virzì GM; Clementi A; Ronco C
    Heart Fail Rev; 2016 Mar; 21(2):177-89. PubMed ID: 26852141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurohormonal, Endocrine, and Immune Dysregulation and Inflammation in Cardiorenal Syndrome.
    Clementi A; Virzì GM; Battaglia GG; Ronco C
    Cardiorenal Med; 2019; 9(5):265-273. PubMed ID: 31266023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress in the cardiorenal metabolic syndrome.
    Whaley-Connell A; Sowers JR
    Curr Hypertens Rep; 2012 Aug; 14(4):360-5. PubMed ID: 22581415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiorenal Syndrome in Acute Kidney Injury.
    Di Lullo L; Reeves PB; Bellasi A; Ronco C
    Semin Nephrol; 2019 Jan; 39(1):31-40. PubMed ID: 30606406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiorenal syndrome: long road between kidney and heart.
    Junho CVC; Trentin-Sonoda M; Panico K; Dos Santos RSN; Abrahão MV; Vernier ICS; Fürstenau CR; Carneiro-Ramos MS
    Heart Fail Rev; 2022 Nov; 27(6):2137-2153. PubMed ID: 35133552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role and Mechanism of the Renin-Angiotensin-Aldosterone System in the Onset and Development of Cardiorenal Syndrome.
    Ma K; Gao W; Xu H; Liang W; Ma G
    J Renin Angiotensin Aldosterone Syst; 2022; 2022():3239057. PubMed ID: 35111237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney and heart interactions during cardiorenal syndrome: a molecular and clinical pathogenic framework.
    Napoli C; Casamassimi A; Crudele V; Infante T; Abbondanza C
    Future Cardiol; 2011 Jul; 7(4):485-97. PubMed ID: 21797745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance and heart failure: molecular mechanisms.
    Aroor AR; Mandavia CH; Sowers JR
    Heart Fail Clin; 2012 Oct; 8(4):609-17. PubMed ID: 22999243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in pathogenesis and current therapeutic strategies for cardiorenal syndrome.
    Du Y; Li X; Liu B
    Life Sci; 2014 Mar; 99(1-2):1-6. PubMed ID: 24140889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiorenal Syndrome and Heart Failure-Challenges and Opportunities.
    Yogasundaram H; Chappell MC; Braam B; Oudit GY
    Can J Cardiol; 2019 Sep; 35(9):1208-1219. PubMed ID: 31300181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
    Cruz DN; Schmidt-Ott KM; Vescovo G; House AA; Kellum JA; Ronco C; McCullough PA
    Contrib Nephrol; 2013; 182():117-36. PubMed ID: 23689659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenetic Pathways of Cardiorenal Syndrome and their Possible Therapeutic Implications.
    Matsushita K
    Curr Pharm Des; 2016; 22(30):4629-4637. PubMed ID: 27160756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.